Mannose-binding lectin (MBL) and post-operative complications/bypass patency with arterial operations

Withdrawn

• Conditions: Mannose-binding lectin genotype; Post-operative complications; 10003216

• Registration Number: NL-OMON37369
• Lead Sponsor: Atrium Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 2000

Inclusion Criteria

Patients with an arterial operation, whereby we will differentiate between femoral and crural.

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The outcome were we will be particularly focus on are the genotype of MBL. Next<br /><br>to this are the post-operative complications (wound infections, re-operations,<br /><br>amputations etc.) correlated. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Possible secundair outcomes values are, recovery measured in time and<br /><br>eventually longer term comlications. </p><br>